NCT06145607View on ClinicalTrials.gov

A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

February 26, 2024

Conditions
Healthy
Interventions
DRUG

ABBV-CLS-7262

ABBV-CLS-7262

Trial Locations (1)

60030

AbbVie Clinical Pharmacology Research Unit (ACPRU), Grayslake

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Calico Life Sciences LLC

INDUSTRY